spotlight on future therapeutics

Deep brain stimulation – implants in the brain that act as a kind of ‘pacemaker’ – has led to clinical improvements in half of the participants with...

A teenager who has lost family members including her mother because of a rare genetic hereditary illness has become the first patient in the UK and...

Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that...

Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of...

An international team has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS)...

Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against SARS...

Cambridge researchers are using new techniques to distinguish different types of medulloblastoma, a type of brain tumour in children.

Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes. The device – powered by an...

Cambridge researchers are jointly leading the first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer.

Cambridge researchers have discovered how T cells – an important component of our immune system – are able to keep on killing as they hunt down and...